Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
129.2 USD | -0.69% | +1.84% | +18.53% |
30/04 | BioMed X Announces the Start of A New Research Project in Partnership with Merck | CI |
29/04 | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.53% | 330B | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B | |
-11.01% | 145B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck & Company's Keytruda Plus Chemotherapy Combination Approved in Japan for Initial Esophageal Cancer Treatment